Free Trial

Grace Therapeutics (GRCE) Institutional Ownership

Grace Therapeutics logo
$2.19 -0.06 (-2.67%)
Closing price 05/14/2026 04:00 PM Eastern
Extended Trading
$2.19 0.00 (-0.18%)
As of 09:26 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Grace Therapeutics (NASDAQ:GRCE)

Current
Institutional Ownership
Percentage
6.08%
Number of
Institutional Buyers
(last 12 months)
11
Total
Institutional Inflows
(last 12 months)
$5.08M
Number of
Institutional Sellers
(last 12 months)
2
Total
Institutional Outflows
(last 12 months)
$1.26M
Get GRCE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Grace Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

GRCE Institutional Buying and Selling by Quarter

Grace Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/14/2026Renaissance Technologies LLC243,910$1.13M0.0%+87.9%1.577%
5/14/2026Pale Fire Capital SE37,762$175K0.0%N/A0.244%
4/20/2026 Kestra Private Wealth Services LLC13,000$60K0.0%N/A0.084%
2/18/2026XTX Topco Ltd30,261$106K0.0%N/A0.196%
2/17/2026ADAR1 Capital Management LLC641,988$2.22M0.2%+83.2%4.149%
2/12/2026Renaissance Technologies LLC129,781$449K0.0%+53.5%0.839%
2/11/2026Cerity Partners LLC422,732$1.46M0.0%N/A2.733%
1/20/2026 Stratos Wealth Partners LTD.11,182$39K0.0%N/A0.072%
11/17/2025Citadel Advisors LLC27,265$81K0.0%-20.7%0.197%
11/14/2025ADAR1 Capital Management LLC350,450$1.04M0.1%+98.4%2.534%
11/13/2025 SeaCrest Wealth Management LLC14,000$42K0.0%N/A0.101%
10/31/2025 AIGH Capital Management LLC907,217$2.70M0.8%-19.6%6.560%
8/13/2025 Millington Financial Advisors LLC20,000$59K0.0%N/A0.145%
7/29/2025 AIGH Capital Management LLC1,128,497$3.35M1.5%-14.7%8.160%
7/15/2025 Palumbo Wealth Management LLC48,541$144K0.0%N/A0.351%
5/16/2025ADAR1 Capital Management LLC343,512$783K0.1%N/A3.388%
5/15/2025Nantahala Capital Management LLC1,178,203$2.69M0.1%N/A11.619%
5/14/2025Stonepine Capital Management LLC294,550$666K0.6%N/A2.905%


GRCE Institutional Ownership - Frequently Asked Questions

During the previous two years, 14 institutional investors and hedge funds held shares of Grace Therapeutics. The most heavily invested institutionals were AIGH Capital Management LLC ($2.70M), Nantahala Capital Management LLC ($2.69M), ADAR1 Capital Management LLC ($2.22M), Cerity Partners LLC ($1.46M), Renaissance Technologies LLC ($1.13M), Stonepine Capital Management LLC ($666K), and Pale Fire Capital SE ($175K).Learn more on Grace Therapeutics' institutional investors.

6.08% of Grace Therapeutics' stock is owned by institutional investors. Learn more on GRCE's institutional investor holdings.

Of the 12 institutional investors that purchased Grace Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Nantahala Capital Management LLC ($1.18M), ADAR1 Capital Management LLC ($808.87K), Cerity Partners LLC ($422.73K), Stonepine Capital Management LLC ($294.55K), Renaissance Technologies LLC ($159.35K), Palumbo Wealth Management LLC ($48.54K), and Pale Fire Capital SE ($37.76K).

Institutional investors have bought a total of 1,565,700 shares in the last 24 months. This purchase volume represents approximately $5.08M in transactions.

The following institutional investors have sold Grace Therapeutics stock in the last 24 months: AIGH Capital Management LLC ($415.16K), and Citadel Advisors LLC ($7.12K).

Institutional investors have sold a total of 422,279 shares in the last 24 months. This volume of shares sold represents approximately $1.26M in transactions.



This page (NASDAQ:GRCE) was last updated on 5/15/2026 by MarketBeat.com Staff.
From Our Partners